<DOC>
	<DOCNO>NCT02376322</DOCNO>
	<brief_summary>Literature show hypofractionated radiotherapy regimen efficacious patient complicate bone metastasis low potential severe treatment-related toxicity . There clear need hypofractionated schedule complicate bone metastasis population , especially consider overarch aim palliative radiotherapy clinical feature patient population . As well , current research examining hypofractionated approach bone metastases patient impend pathologic fracture , neuropathic pain accompany soft tissue mass markedly scarce .</brief_summary>
	<brief_title>Hypofractionated Radiotherapy ( 16/2 ) Palliation Complicated Bone Metastases Patients With KPS</brief_title>
	<detailed_description>In response already comment , purpose one arm , phase II trial determine efficacy safety profile hypofractionated radiotherapy regimen , 16 Gy 2 fraction interval one week , palliation complicate bone metastasis patient poor performance status .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<criteria>1 . Histologically cytologically proven malignancy . 2 . Patients age 18 . 3 . Advanced cancer patient least one complicate bone metastasis . A complicated bone metastasis operationally define bone metastasis accompanying : soft tissue mass extraosseous component penetrate normal cortical boundary ; neuropathic pain ; post surgical intervention bone fixation ; impending fracture high fracture risk weight bear long bone define Harrington 's criterion surgical candidate : lytic bone lesion involve Â½ diameter bone cortex , great 2.5 cm great diameter , intertrochanteric line ( 29 ) . 4 . Patients Karnofsky Performance Status ( KPS ) 3060 time baseline evaluation . 5 . Patients plan receive radiation treatment complicate site ( ) follow study . 6 . Patients surgery complicate bone metastasis . 7 . Patients currently take systemic therapy ( i.e . chemotherapy , hormone therapy , bone modify agent ) plan begin systemic therapy within two week treatment allow participate study ; study personnel note use systemic therapy study record . 8 . Patients able provide bad pain score complicate site ( ) follow study . 9 . Patients able willing fill daily diary . 10 . Patients able provide inform consent prior enrol study . 1 . Patients leukemia Hodgkin's/nonHodgkin 's lymphoma . 2 . Patients surgical candidate pathologic fracture lesion high risk pathologic fracture humerus , radius , ulna , femur , tibia , fibula . They eligible postoperative hypofractionated radiotherapy . 3 . Patients spinal cord compression cauda equina syndrome . 4 . Patients currently receive radiopharmaceutical . 5 . Patients unable record pain score , complete daily diary communicate request information study personnel .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>